Opportunity Information: Apply for HRSA 22 033

  • The Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Ryan White HIV/AIDS Program HIV Care Grant Program – Part B States/Territories Formula and AIDS Drug Assistance Program Formula and ADAP Supplemental Awards" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.917.
  • This funding opportunity was created on 2021-07-23.
  • Applicants must submit their applications by 2021-11-08. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2025.)
  • The number of recipients for this funding is limited to 59 candidate(s).
  • Eligible applicants include: State governments.
Apply for HRSA 22 033

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for HIV and AIDS support

Browse more opportunities from the same agency: Health Resources and Services Administration

Browse more opportunities from the same category: Health

Previous opportunity: Development, testing, and refinement of engineering systems for monitoring acoustic resources and other environmental conditions in National Parks

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for HRSA 22 033

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (HRSA 22 033) also looked into and applied for these:

Funding Opportunity
Ryan White HIV/AIDS Program Part B States/Territories Supplemental Grant Program Apply for HRSA 22 034

Funding Number: HRSA 22 034
Funding Amount: Case Dependent
Pilot Studies to Test the Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34 Clinical Trial Required) Apply for PAR 21 292

Funding Number: PAR 21 292
Funding Amount: Case Dependent
Comprehensive High Impact Community Based HIV Prevention, Testing and Treatment Initiation for Sustained Epidemic Control in Lesotho under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH22 2221

Funding Number: CDC RFA GH22 2221
Funding Amount: Case Dependent
Addressing Unmet Need in HIV Testing Services (HTS) for Priority Populations and HIV/AIDS Services for Key Populations Through Effective Delivery Models in Malawi under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH22 2217

Funding Number: CDC RFA GH22 2217
Funding Amount: Case Dependent
Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 - Clinical Trial Required) Apply for RFA MD 22 001

Funding Number: RFA MD 22 001
Funding Amount: $500,000
Limited Competition:Caenorhabditis Intervention Testing Program Data Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA AG 22 028

Funding Number: RFA AG 22 028
Funding Amount: $200,000
Limited Competition: Renewal of the Caenorhabditis Intervention Testing Program (U01 Clinical Trial Not Allowed) Apply for RFA AG 22 029

Funding Number: RFA AG 22 029
Funding Amount: $600,000
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Testing Laboratories (U01 Clinical Trial Not Allowed) Apply for RFA NS 22 003

Funding Number: RFA NS 22 003
Funding Amount: $400,000
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) Apply for RFA HL 23 014

Funding Number: RFA HL 23 014
Funding Amount: $250,000
Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) Apply for RFA HL 23 013

Funding Number: RFA HL 23 013
Funding Amount: Case Dependent
Enhanced surveillance of persons with early and late HIV diagnosis to understand system and individual factors associated with new infection and delayed testing Apply for CDC RFA PS22 2211

Funding Number: CDC RFA PS22 2211
Funding Amount: Case Dependent
Partnerships for Rapid Diagnostics and Phenotypic Antibacterial Susceptibility Testing for Bacteremia or Hospital Acquired Pneumonia (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 010

Funding Number: RFA AI 22 010
Funding Amount: Case Dependent
Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 016

Funding Number: RFA AI 22 016
Funding Amount: $500,000
Mass Mailing of HIV Self-Tests to Persons Disproportionately Affected by HIV in the U.S. Apply for CDC RFA PS22 2210

Funding Number: CDC RFA PS22 2210
Funding Amount: Case Dependent
Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 - Clinical Trial Required) Apply for RFA MD 22 009

Funding Number: RFA MD 22 009
Funding Amount: $500,000
Ryan White HIV/AIDS Program Part B States/Territories Supplemental Grant Program Apply for HRSA 23 055

Funding Number: HRSA 23 055
Funding Amount: $9,000,000
Network for Personalization of Diagnostic Tests for Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) in Older Adults with Multiple Chronic Conditions (MCCs) (U24 Clinical Trial Optional) Apply for RFA AG 23 032

Funding Number: RFA AG 23 032
Funding Amount: $1,150,000
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) Apply for PAR 23 032

Funding Number: PAR 23 032
Funding Amount: $350,000
Testing Centers for Development of Somatic Cell Genome Editing in Model Organisms (U42) (Clinical Trials Not Allowed) Apply for PAR 23 038

Funding Number: PAR 23 038
Funding Amount: $500,000
Renewal of the Interventions Testing Program (U01 Clinical Trial Not Allowed) Apply for RFA AG 24 002

Funding Number: RFA AG 24 002
Funding Amount: $3,000,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 22 033", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

OSZAR »